THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

A rare but troubling side effect

New concerns about blood clots associated with drug-coated stents could hurt Boston Scientific's bottom line as doctors grow more wary about them

By Stephen Heuser
Globe Staff / September 18, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The product is one of the biggest-selling medical devices in history. The side effect is rare and deadly. And the impact is a giant question mark hanging over Boston Scientific Corp. , the region's biggest life-science company. (Full article: 1273 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass